U.S. Gastroenterology Ambulatory Surgery Centers Market
U.S. Gastroenterology Ambulatory Surgery Centers Market Report 2024-2030 - Corporation-Ownership is Expected to Grow at a CAGR of 5.4%
15 oct. 2024 04h20 HE | Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "U.S. Gastroenterology Ambulatory Surgery Centers Market Size, Share and Trends Analysis Report by Ownership (Hospital-Affiliated, Freestanding,...
Physician Growth Partners Advises Digestive Disease Consultants in a Partnership With One GI
19 janv. 2022 09h00 HE | Physician Growth Partners
CHICAGO, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Physician Growth Partners ("PGP") is proud to have advised Digestive Disease Consultants ("DDC" or "the Practice") in a transaction with One GI, a private...
ritter.jpg
Ritter Pharmaceuticals Highlights Key Phase 2b Clinical Trial Data of RP-G28 for Lactose Intolerance at Digestive Disease Week 2018
05 juin 2018 08h30 HE | Ritter Pharmaceuticals, Inc.
Additional Data Describes Novel Clinical Symptom Assessment Tool Developed in Phase 2b Trial and to be Used in Upcoming Phase 3 Clinical Trial LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- Ritter...
crinetics.png
Crinetics Pharmaceuticals Awarded Two SBIR Grants to Develop New Therapeutics for Congenital Hyperinsulinism and Cushing’s Disease
06 sept. 2017 09h00 HE | Crinetics Pharmaceuticals, Inc.
SAN DIEGO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, announced today that...